FR2393579A1 - Agent antiviral et son application au traitement des affections virales - Google Patents

Agent antiviral et son application au traitement des affections virales

Info

Publication number
FR2393579A1
FR2393579A1 FR787816958A FR7816958A FR2393579A1 FR 2393579 A1 FR2393579 A1 FR 2393579A1 FR 787816958 A FR787816958 A FR 787816958A FR 7816958 A FR7816958 A FR 7816958A FR 2393579 A1 FR2393579 A1 FR 2393579A1
Authority
FR
France
Prior art keywords
treatment
antiviral agent
application
viral disorders
viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR787816958A
Other languages
English (en)
Other versions
FR2393579B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Seika Kaisha Ltd
Original Assignee
Meiji Seika Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha Ltd filed Critical Meiji Seika Kaisha Ltd
Publication of FR2393579A1 publication Critical patent/FR2393579A1/fr
Application granted granted Critical
Publication of FR2393579B1 publication Critical patent/FR2393579B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

Cet agent antiviral pour la prévention thérapeutique et le traitement d'une maladie virale chez les animaux à sang chaud, y compris chez l'homme, et chez les poissons, contient, comme ingrédient actif, une quantité antiviralement efficace d'au moins un dérivé de glycine de formule générale:
FR787816958A 1977-06-06 1978-05-31 Agent antiviral et son application au traitement des affections virales Granted FR2393579A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6573977A JPS542336A (en) 1977-06-06 1977-06-06 Preventive and remedy for viral diseases

Publications (2)

Publication Number Publication Date
FR2393579A1 true FR2393579A1 (fr) 1979-01-05
FR2393579B1 FR2393579B1 (fr) 1980-06-13

Family

ID=13295678

Family Applications (1)

Application Number Title Priority Date Filing Date
FR787816958A Granted FR2393579A1 (fr) 1977-06-06 1978-05-31 Agent antiviral et son application au traitement des affections virales

Country Status (6)

Country Link
US (1) US4216226A (fr)
JP (1) JPS542336A (fr)
CA (1) CA1098827A (fr)
DE (1) DE2823346C2 (fr)
FR (1) FR2393579A1 (fr)
GB (1) GB1599612A (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2377197A1 (fr) * 1977-01-13 1978-08-11 Hoffmann La Roche Procede de diagnostic pour detecter un defaut d'absorption des acides amines, des sucres, des graisses, des vitamines et des sels mineraux
EP0009728A1 (fr) * 1978-09-23 1980-04-16 Hokuriku Pharmaceutical Co.,Ltd Agent hémostatique et augmentant les plaquettes sanguines, contenant l'acide alpha-bêta-diaminopropionique et ses dérivés
EP0313094A2 (fr) * 1987-10-22 1989-04-26 Meiji Seika Kaisha Ltd. Médicament anticancéreux et réactif pour l'obtention des revertants

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2941384A1 (de) * 1979-10-12 1981-04-23 Bayer Ag, 5090 Leverkusen Phosphono-hydroxy-essigsaeure, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE19843222A1 (de) * 1998-09-22 2000-03-30 Hassan Jomaa Verwendung von phosphororganischen Verbindungen zur therapeutischen und prophylaktischen Behandlung von Infektionen
EP1281767A3 (fr) * 2001-07-31 2003-05-28 Aladar A. Szalay Microbes et cellules lumineuses pour le diagnostic et le traitement des tumeurs
CN100562570C (zh) 2003-06-18 2009-11-25 吉恩勒克斯公司 修饰的重组痘苗病毒及其它微生物,及其应用
US20090098529A1 (en) 2006-10-16 2009-04-16 Nanhai Chen Methods for attenuating virus strains for diagnostic and therapeutic uses
US20090117034A1 (en) * 2007-06-15 2009-05-07 Nanhai Chen Microorganisms for imaging and/or treatment of tumors
US11149254B2 (en) 2011-04-15 2021-10-19 Genelux Corporation Clonal strains of attenuated vaccinia viruses and methods of use thereof

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2377197A1 (fr) * 1977-01-13 1978-08-11 Hoffmann La Roche Procede de diagnostic pour detecter un defaut d'absorption des acides amines, des sucres, des graisses, des vitamines et des sels mineraux
EP0009728A1 (fr) * 1978-09-23 1980-04-16 Hokuriku Pharmaceutical Co.,Ltd Agent hémostatique et augmentant les plaquettes sanguines, contenant l'acide alpha-bêta-diaminopropionique et ses dérivés
EP0313094A2 (fr) * 1987-10-22 1989-04-26 Meiji Seika Kaisha Ltd. Médicament anticancéreux et réactif pour l'obtention des revertants
EP0313094A3 (en) * 1987-10-22 1990-08-29 Meiji Seika Kaisha Ltd. Anticancer agent and reagent for obtaining revertants

Also Published As

Publication number Publication date
DE2823346C2 (de) 1985-04-11
FR2393579B1 (fr) 1980-06-13
JPS542336A (en) 1979-01-09
CA1098827A (fr) 1981-04-07
GB1599612A (en) 1981-10-07
DE2823346A1 (de) 1978-12-14
US4216226A (en) 1980-08-05

Similar Documents

Publication Publication Date Title
MA27121A1 (fr) Derives 2-(purin-9-yl)-tetrahydrofuran-3,4-diol
MA27156A1 (fr) NUCLEOSIDES 3- β-D-RIBOFURANOSYLTHIAZOLO[4,5-d] PYRIDIMINE ET LES UTILISATIONS DE CELLES-CI
FR2435471A1 (fr) Derives de dihydropyridine, procedes d'obtention et compositions pharmaceutiques en contenant
ATE219363T1 (de) Lösliche prodrugs von paclitaxel
TNSN97091A1 (fr) CONJUGUE PEG-IFN α PHYSIOLOGIQUEMENT ACTIF, PROCEDE POUR SA PREPARATION, COMPOSITIONS PHARMACEUTIQUES LE CONTENANT ET LEUR UTILISATION
DE9320925U1 (de) Terfenadin-Metabolite und deren optisch reine Isomere für die Behandlung von allergischen Störungen
HUT67436A (en) Process to prepare novel hydroxamic acid and n-hydroxyurea derivatives and pharmaceutical compn.s contg. them
FR2434155A1 (fr) Derives d'imidazole et leur utilisation pour le traitement des maladies provoquees par le thromboxane a2
DK162883D0 (da) N-glucosylerede carboxylsyreamidderivater, fremgangsmade til fremstilling heraf samt deres anvendelse til pavirkning af organismens egen forsvarsmekanisme
DE69526353D1 (de) Immunologische aktivität der rhamnolipide
FR2361901A1 (fr) Derives de substitution de nucleotides et medicament contenant ces substances
FR2393579A1 (fr) Agent antiviral et son application au traitement des affections virales
DE4394931T1 (de) Verwendung von Norastemizol zur Behandlung von allergischen Erkrankungen
FR2354324A1 (fr) Nouveaux composes triazoliques, leur procede de preparation et leurs applications au traitement de plantes
FR2387988A1 (fr) Esters de cefuroxime, leur preparation et leur application therapeutique
FR2430418A1 (fr) Derives halogenomethyles d'a-aminoacides, leur preparation et leurs utilisations therapeutiques
TNSN90021A1 (fr) Procede de preparation de tetrahydroimidazo (1,4) benzodiazepin -2- thiones antivirales
FR2405067A1 (fr) Compositions pharmaceutiques contenant des derives monofonctionnels du psoralene pour le traitement des affections cutanees
FR2445328A1 (fr) Derives du 14-oxo-e-homo-eburnane, leur procede de preparation et leur utilisation comme medicament
FR2420344A1 (fr) Nouveaux oxime-ethers, leur preparation et leur application therapeutique.
FR2405657A1 (fr) Agent favorisant la croissance des animaux
FR2362587A1 (fr) Agents antimicrobie
FR2428436A1 (fr) Nouvelles compositions cosmetiques pour le traitement de l'etat gras des cheveux et de la peau, composes nouveaux et leur procede de preparation
FR2369837A1 (fr) Derives actifs de l'uree, leur procede de preparation ainsi que les compositions therapeutiques les contenant
ATE110714T1 (de) Derivate von hydroxaminsäure die lipoxygenase hemmen.

Legal Events

Date Code Title Description
ST Notification of lapse